Sabra Health Care REIT, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Sabra Health Care REIT, Inc. (Sabra) on July 30, 2025. The filing discloses the entry into a material definitive agreement involving new debt financing and the redemption of existing senior notes.
Key Financial Metrics and Debt Structure
- New Term Loan: Entered into a $500.0 million unsecured term loan with a maturity date of July 30, 2030.
- Interest Rate: The loan bears interest at a ratings-based margin plus SOFR or Base Rate. Through the use of interest rate swaps, the effective interest rate is fixed at 4.64% through maturity.
- Debt Capacity: The agreement includes an accordion feature allowing total borrowings to increase to $1.0 billion.
- Debt Redemption: Sabra redeemed $500.0 million of 5.125% Senior Notes due 2026 at a price of 100.575% of principal plus accrued interest.
- Covenants: The new agreement includes standard financial covenants regarding leverage ratios, fixed charge coverage, and adjusted net worth.
Material Changes
The primary material change is the refinancing of $500.0 million in debt. Sabra replaced its 2026 Senior Notes (carrying a 5.125% coupon) with a new 5-year term loan carrying an effective rate of 4.64%. This transaction extends the maturity profile of this debt tranche from 2026 to 2030 and reduces the effective interest cost.
Outlook, Risks, and Contingencies
The filing does not provide updated revenue guidance or profit outlooks. However, the new credit agreement imposes customary restrictions on dividends, additional indebtedness, and asset sales. The company has hedged interest rate risk for the new loan via forward-starting swaps. The redemption of the 2026 Notes was executed at a premium (100.575%), representing a cash outflow slightly above par value.
Investor Verification Checklist
- Verify the exact cash outflow for the 2026 Notes redemption, including the premium and accrued interest.
- Confirm the current Debt Ratings to determine the specific applicable interest margin (ranging from 0.800% to 1.600% for SOFR) under the new agreement.
- Review the full text of the Credit Agreement (Exhibit 10.1) for specific definitions of the financial covenants and potential default triggers.
- Assess the impact of the new debt structure on the company's overall weighted average cost of capital and liquidity position.